zonisamide has been researched along with Adenoma Sebaceum in 3 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Adenoma Sebaceum: Facial ANGIOFIBROMA in tuberous sclerosis
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examined the efficacy and safety of zonisamide as monotherapy in pediatric patients with epilepsy." | 9.11 | Effects of zonisamide monotherapy in children with epilepsy. ( Kumagai, N; Maezawa, M; Seki, T, 2004) |
| "Zonisamide (ZNS) is a new generation antiepileptic drug (AED) used in refractory epilepsy." | 8.12 | Effectiveness of zonisamide in childhood refractory epilepsy. ( Aslan, M; Gungor, S, 2022) |
| "A 11 year-old boy with tuberous sclerosis complex and left frontal refractory epilepsy, evaluated within a paediatric epilepsy surgery program." | 5.42 | [Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis]. ( Blanco-Beregana, M; Budke, M; Fournier-Del Castillo, MC; Garcia-Fernandez, M; Garcia-Penas, JJ; Melero-Llorente, J; Perez-Jimenez, MÁ; Robles-Bermejo, F, 2015) |
| "This study examined the efficacy and safety of zonisamide as monotherapy in pediatric patients with epilepsy." | 5.11 | Effects of zonisamide monotherapy in children with epilepsy. ( Kumagai, N; Maezawa, M; Seki, T, 2004) |
| "Zonisamide (ZNS) is a new generation antiepileptic drug (AED) used in refractory epilepsy." | 4.12 | Effectiveness of zonisamide in childhood refractory epilepsy. ( Aslan, M; Gungor, S, 2022) |
| "A 11 year-old boy with tuberous sclerosis complex and left frontal refractory epilepsy, evaluated within a paediatric epilepsy surgery program." | 1.42 | [Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis]. ( Blanco-Beregana, M; Budke, M; Fournier-Del Castillo, MC; Garcia-Fernandez, M; Garcia-Penas, JJ; Melero-Llorente, J; Perez-Jimenez, MÁ; Robles-Bermejo, F, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, M | 1 |
| Gungor, S | 1 |
| Fournier-Del Castillo, MC | 1 |
| Melero-Llorente, J | 1 |
| Blanco-Beregana, M | 1 |
| Robles-Bermejo, F | 1 |
| Budke, M | 1 |
| Garcia-Fernandez, M | 1 |
| Garcia-Penas, JJ | 1 |
| Perez-Jimenez, MÁ | 1 |
| Seki, T | 1 |
| Kumagai, N | 1 |
| Maezawa, M | 1 |
1 trial available for zonisamide and Adenoma Sebaceum
| Article | Year |
|---|---|
Effects of zonisamide monotherapy in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Administration Schedule; Electroencephalo | 2004 |
2 other studies available for zonisamide and Adenoma Sebaceum
| Article | Year |
|---|---|
Effectiveness of zonisamide in childhood refractory epilepsy.
Topics: Child; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Humans; Reproducibility of Results; R | 2022 |
[Reversible neuropsychological deterioration associated to zonisamide in a paediatric patient with tuberous sclerosis].
Topics: Acetamides; Anticonvulsants; Benzodiazepines; Child; Clobazam; Cognition Disorders; Dibenzazepines; | 2015 |